Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators

Table 3 Summary of barriers and facilitators from the qualitative data

	Barriers	Facilitators
Patient perspective	Lack of knowledge around liver health, HCV infection and DAA treatment	Patients’ positive relationships with providers and trust in the health system
	Difficultly in accessing treatment and testing due to financial hardship	Support from family and community members
	Cumbersome treatment process and unpredictable appointment schedules
Healthcare provider perspective	Heavy work-loads and lack of HCV training	Lack of stigma and a supportive community
	High cost associated with HCV treatment	Dedication of healthcare providers
	Challenges in information availability	Patients experience only minor side effects and are motivated to engage in care
	Difficulty in accessing diagnostics technology and results

ISSN: 1471-2458